High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).

Saved in:
Bibliographic Details
Title: High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).
Authors: Nair-Shalliker V; The Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, NSW, Australia. visalinin@nswcc.org.au.; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia. visalinin@nswcc.org.au., Smith DP; The Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, NSW, Australia.; School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Patel MI; School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia.; Specialty of Surgery, Westmead Hospital, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Frydenberg M; Department of Surgery, Monash University, Cabrini Institute, Cabrini Health, Clayton, VIC, Australia., Yaxley J; Royal Brisbane and Women's Hospital, Herston, QLD, Australia.; University of Queensland, St Lucia, QLD, Australia., Gardiner R'; University of Queensland, St Lucia, QLD, Australia., Espinoza D; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia., Kimlin MG; Bond University, Robina, Queensland, Australia., Dhillon V; Clinical and Health Sciences, University of South Australia, Sydney, SA, Australia., Leifert W; The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health & Biosecurity, Human Health Program, Sydney, SA, Australia., Gillatt D; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia., Woo H; Department of Urology, Blacktown Hospital, Sydney, NSW, Australia.; Department of Uro-Oncology, Chris O'Brien Lifehouse, Camperdown, Sydney, NSW, Australia., Rasiah K; Royal North Shore Hospital, Sydney, NSW, Australia., Awad N; Urology Centre Port Macquarie, Sydney, NSW, Australia.; University of New South Wales, Rural School of Medicine, Port Macquarie, Sydney, NSW, Australia., Symons J; School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia.; Sydney Adventist Hospital, NSW, Sydney, Australia., Wells JK; Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia., Pickett HA; Children's Medical Research Institute, Faculty of Medicine and Health, University of Sydney, Westmead, NSW, Australia., Fenech M; Clinical and Health Sciences, University of South Australia, Sydney, SA, Australia., Anderson PH; Clinical and Health Sciences, University of South Australia, Sydney, SA, Australia., Armstrong BK; School of Public Health, The University of Western Australia, Perth, WA, Australia., Gurney H; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
Source: British journal of cancer [Br J Cancer] 2026 Mar; Vol. 134 (5), pp. 735-745. Date of Electronic Publication: 2025 Dec 21.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-025-03278-w